Pharmaceutical company seeks U.S. FDA approval ciprofloxacin otic 0.2% solution

Salvat announce plans to file its Cetraxal Otic solution, with a single-dispensing container (SDC) format, with the U.S. Food and Drug Administration (FDA). The efficacy and safety of the treatment [...]